BMAL2 is a druggable target for ovarian clear cell carcinoma (OCCC).
Saved in:
| Title: | BMAL2 is a druggable target for ovarian clear cell carcinoma (OCCC). |
|---|---|
| Authors: | Tan GYT; Molecular and Cell Biology, Taiwan International Graduate Program, Academia Sinica and National Defense Medical University, Taipei, 11490, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, 115201, Taiwan., Lin PY; Genomics Research Center, Academia Sinica, Taipei, 115201, Taiwan., Cheng LT; Molecular and Cell Biology, Taiwan International Graduate Program, Academia Sinica and National Defense Medical University, Taipei, 11490, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, 115201, Taiwan., Tsai Yuan YS; Department of Chemistry, National Taiwan University, Taipei, 106319, Taiwan., Huang SH; Institute of Biochemical Sciences, National Taiwan University, Taipei, 106319, Taiwan., Yu CA; Institute of Molecular Biology, Academia Sinica, Taipei, 115201, Taiwan., Chen CT; Department of Chemistry, National Taiwan University, Taipei, 106319, Taiwan., Chi P; Institute of Biochemical Sciences, National Taiwan University, Taipei, 106319, Taiwan., Hwang-Verslues WW; Genomics Research Center, Academia Sinica, Taipei, 115201, Taiwan. wendyhv@as.edu.tw. |
| Source: | EMBO molecular medicine [EMBO Mol Med] 2026 May; Vol. 18 (5), pp. 1933-1966. Date of Electronic Publication: 2026 Apr 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41933240 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: BMAL2 is a druggable target for ovarian clear cell carcinoma (OCCC). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tan+GYT%22">Tan GYT</searchLink>; Molecular and Cell Biology, Taiwan International Graduate Program, Academia Sinica and National Defense Medical University, Taipei, 11490, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, 115201, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+PY%22">Lin PY</searchLink>; Genomics Research Center, Academia Sinica, Taipei, 115201, Taiwan.<br /><searchLink fieldCode="AU" term="%22Cheng+LT%22">Cheng LT</searchLink>; Molecular and Cell Biology, Taiwan International Graduate Program, Academia Sinica and National Defense Medical University, Taipei, 11490, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, 115201, Taiwan.<br /><searchLink fieldCode="AU" term="%22Tsai+Yuan+YS%22">Tsai Yuan YS</searchLink>; Department of Chemistry, National Taiwan University, Taipei, 106319, Taiwan.<br /><searchLink fieldCode="AU" term="%22Huang+SH%22">Huang SH</searchLink>; Institute of Biochemical Sciences, National Taiwan University, Taipei, 106319, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yu+CA%22">Yu CA</searchLink>; Institute of Molecular Biology, Academia Sinica, Taipei, 115201, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+CT%22">Chen CT</searchLink>; Department of Chemistry, National Taiwan University, Taipei, 106319, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chi+P%22">Chi P</searchLink>; Institute of Biochemical Sciences, National Taiwan University, Taipei, 106319, Taiwan.<br /><searchLink fieldCode="AU" term="%22Hwang-Verslues+WW%22">Hwang-Verslues WW</searchLink>; Genomics Research Center, Academia Sinica, Taipei, 115201, Taiwan. wendyhv@as.edu.tw. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101487380%22">EMBO molecular medicine</searchLink> [EMBO Mol Med] 2026 May; Vol. 18 (5), pp. 1933-1966. <i>Date of Electronic Publication: </i>2026 Apr 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22EMBO+Press%22">EMBO Press </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101487380 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1757-4684 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217574676%22">17574676 </searchLink><i>NLM ISO Abbreviation: </i>EMBO Mol Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41933240 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s44321-026-00414-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1933 Titles: – TitleFull: BMAL2 is a druggable target for ovarian clear cell carcinoma (OCCC). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tan GYT – PersonEntity: Name: NameFull: Lin PY – PersonEntity: Name: NameFull: Cheng LT – PersonEntity: Name: NameFull: Tsai Yuan YS – PersonEntity: Name: NameFull: Huang SH – PersonEntity: Name: NameFull: Yu CA – PersonEntity: Name: NameFull: Chen CT – PersonEntity: Name: NameFull: Chi P – PersonEntity: Name: NameFull: Hwang-Verslues WW IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1757-4684 Numbering: – Type: volume Value: 18 – Type: issue Value: 5 Titles: – TitleFull: EMBO molecular medicine Type: main |
| ResultId | 1 |